Page 10 - Bharat Biotech
Supporting 3 PSUs, Bharat Biotech facility for more Covaxin doses: Govt
Facility augmentation of Bharat Biotech and three public sector enterprises is being supported for enhancing production of COVID-19 vaccine Covaxin, Parliament was informed on Friday. The Department of Biotechnology has informed that the facility augmentation of Bharat Biotech and 3 public sector enterprises (PSEs) Haffkine Biopharmaceutical Corporation Ltd, Indian Immunologicals Ltd; and Bharat Immunologicals Biologicals Corporation Ltd is being supported for augmented production of Covaxin, Minister of Health & Family Welfare and Chemicals & Fertilizers Mansukh Mandaviya said in a written reply to a question in the Rajya Sabha. This is being done under the 'Mission COVID Suraksha the Indian COVID-19 Vaccine Development Mission', he added. Further, technology transfer of Covaxin production to Gujarat COVID Vaccine Consortium comprising Hester Biosciences, OmniBRx Biotechnologies Pvt Ltd and Gujarat Biotechnology Research Centre is being facilitated by the Department of ..
 "Supporting 3 PSUs, Bharat Biotech facility for more Covaxin doses: Govt")
Over 200 tests for every batch: Bharat Biotech on Covaxin quality concern
Each batch of the vaccine was subjected to more than 200 quality control tests at its facilities, followed by submission samples to CDL. Only based on approval by CDL are batches released commercially
 "Over 200 tests for every batch: Bharat Biotech on Covaxin quality concern")
Production of 1.35 bn vaccine doses between August, December a long haul
Covishield production to cross 120 mn doses a month, Covaxin 58 mn doses a month
 "Production of 1.35 bn vaccine doses between August, December a long haul")
Covaxin receives GMP certificate from Hungary, says Bharat Biotech
Bharat Biotech's Covid-19 vaccine Covaxin has received Good Manufacturing Practices (GMP) compliance certificate from Hungary, the vaccine maker said on Thursday in a tweet
Indian Immunologicals may start supplying 2 mn Covaxin doses by Sep: Govt
NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups related to standardisation quality assurances of batches of vaccines at Bangalore plant, which delayed production
 "Indian Immunologicals may start supplying 2 mn Covaxin doses by Sep: Govt")
Bharat Biotech's Covaxin effective against Delta plus variant, says study
The study released on Monday showed that Covaxin provides 65.2 per cent protection against the Delta variant which was first detected in India
Bharat Biotech's Covaxin effective against Delta Plus variant: ICMR study
Bharat Biotech's Covid-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus, according to a study by the Indian Council of Medical and Research
Bharat Biotech's Rotavac 5D receives WHO Prequalification
Bharat Biotech on Monday announced that the World Health Organisation has awarded prequalification to its rotavirus vaccine,Rotavac 5D to prevent rotavirus diarrhea, the company said.
India may soon have Covid-19 vaccines for children. All you need to know
Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above
 "India may soon have Covid-19 vaccines for children. All you need to know")
Expert panel recommends trials on mixing Covaxin and Covishield
As per sources, the application of the interchangeability study protocol of Covishield and Covaxin was moved by Christian Medical College (CMC) in Vellore.
Covid-19 vaccine for children likely in August: Health minister Mandaviya
Zydus Cadila has done trials on 12-plus; Bharat Biotech conducting trials on two-plus
 "Covid-19 vaccine for children likely in August: Health minister Mandaviya")
India to miss July-end Covid vaccination target as Bharat Biotech lags
The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August.
Brazil suspends clinical trials of Covaxin after termination of agreement
Brazil has suspended the clinical studies of Bharat Biotech's Covaxin following termination of the company's agreement with its partner there, the South American Country's health regulator said
Bharat Biotech axes Covid vaccine deal with Brazil's Precisa: Statement
Bharat's statement said it will continue to work with Brazilian health care regulator Anvisa to obtain all required approvals for the use of Covaxin in the country
Bharat Biotech's Bengaluru unit has overcome glitches, says V K Paul
Bharat Biotech is hoping to manufacture 1 billion doses per annum by the end of this year.
Process to receive WHO pre-qualification for Covaxin on, says govt
Covishield manufactured by the Serum Institute of India (SII) has received the WHO pre-qualification, while the process of pre-qualification for Bharat Biotech's Covaxin is going on
 "Process to receive WHO pre-qualification for Covaxin on, says govt")
Bharat Biotech had agreed to offer vaccine at reasonable rates to Govt: MoH
ICMR has spent Rs 35 cr on Covaxin clinical trials
WHO assessing Covaxin data for EUL; decision date 'to be confirmed'
WHO, which is currently reviewing Bharat Biotech's application for an Emergency Use Listing of its Covid-19 vaccine Covaxin, has said it is assessing the data of the jab
New price good, but Rs 250 a dose better: Covid-19 vaccine makers
Centre has ordered 660 mn doses, expected to be supplied between Aug & Dec
 "New price good, but Rs 250 a dose better: Covid-19 vaccine makers")
Small contract manufacturers wait to take a shot at Covid vaccines
A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors
 "Small contract manufacturers wait to take a shot at Covid vaccines")
